Stifel Nicolaus reiterated its rating of Buy for this company and changed its price target from $8 to $9.
Sentiment: Strong Buy
Finally, it is posted in Yahoo/Finance Headlines. We need more upgrades to reverse the down trend.
We do all read it. But down 7% on the day FDA approval is not normal, ist it? Is there any explain?
Anyway, thank you for your selling, I bought 200k more today.